Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


parkinson@chl.lu


https://www.parkinson.lu/

The National Centre of Excellence in Research on Parkinson’s disease

The OPDC has formed a strategic alliance with the National Centre of Excellence in Research on Parkinson’s disease, a joint research program by all biomedical research partners in Luxembourg led by Rejko Kruger. The research focuses on improving the diagnosis and stratification of Parkinson's disease by combining detailed clinical and molecular data of patients to develop novel disease biomarker signatures. An important component of the Centre will be a Parkinson's patient cohort as a nationwide effort that will establish the core of a future PD-registry in Luxembourg.

The OPDC is one of the international partners working with this study; other partners are the DeNoPa study led by Prof. Britt Mollenhauer (Paracelsus Elena Hospital in Kassel) and the TREND and PMPP cohorts led by Prof. Daniela Berg (Hertie Institute for Clinical Brain Research).